NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Center for Substance Abuse Treatment. Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2004. (Treatment Improvement Protocol (TIP) Series, No. 40.)

Cover of Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction

Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction.

Show details

Appendix J Field Reviewers

  • Emizie Abbott, CCDC III
  • Executive Director
  • Cleveland Treatment Center, Inc.
  • Cleveland, Ohio
  • Patrick Abbott, M.D.
  • Center on Alcoholism, Substance Abuse and Addiction
  • Albuquerque, New Mexico
  • Cynthia E. Aiken, M.S., LPA
  • Executive Director
  • Narcotic Drug Treatment Center, Inc.
  • Anchorage, Alaska
  • Doug Allen, M.S.W.
  • Administrator
  • Planning Policy and Legislative Relations
  • Division of Alcohol and Substance Abuse
  • Department of Social & Health Services
  • State of Washington
  • Olympia, Washington
  • Leslie Amass, Ph.D.
  • Principal Investigator
  • Friends Research Institute, Inc.
  • Los Angeles, California
  • Robert E. Anderson
  • Director, Research and Program Applications
  • National Association of State Alcohol and Drug Abuse Directors
  • Washington, District of Columbia
  • Gerard Armstrong
  • Deputy Director
  • Managed Care/Health and Revenue Services
  • Office of Alcoholism and Substance Abuse Services
  • State of New York
  • New York, New York
  • Judith A. Arroyo, Ph.D.
  • Coordinator
  • Project COMBINE
  • Center on Alcoholism, Substance Abuse and Addictions
  • University of New Mexico
  • Albuquerque, New Mexico
  • Candace L. Baker, MAC, ACSW
  • Director, Clinical Issues
  • The National Association of Alcoholism and Drug Abuse Counselors
  • Arlington, Virginia
  • Doug Baker
  • Head, Adult Services Branch
  • Substance Abuse Services Section
  • Division of Mental Health, Developmental Disabilities and Substance Abuse Services
  • State of North Carolina
  • Raleigh, North Carolina
  • Roxanne Baker
  • Director of Nor‐Cal NAMA
  • Northern California National Alliance of Methadone Advocates
  • Santa Cruz, California
  • Steve Batki, M.D.
  • Professor and Director of Research
  • Department of Psychiatry
  • Upstate Medical University
  • Syracuse, New York
  • Ann Belk
  • Program Analyst
  • Office of Diversion Control
  • Drug Enforcement Administration
  • Washington, District of Columbia
  • Mark Beresky
  • Secretary/Treasurer
  • The Vermont Harm Reduction Coalition
  • Co‐Director, The New England Chapter of the National Alliance of Methadone Advocates
  • Putney, Vermont
  • Bruce J. Berg, M.D.
  • Vice President Medical Services
  • Magellan Behavioral Health
  • Bryn Mawr, Pennsylvania
  • Robert Bick, M.A., SAC
  • Director
  • Champlain Drug and Alcohol Services
  • Howard Center for Human Services
  • Burlington, Vermont
  • George Bigelow, Ph.D.
  • Professor
  • College on Problems of Drug Dependence
  • Behavioral Pharmacology Research Unit
  • Behavioral Biology Research Center
  • Johns Hopkins Bayview Campus
  • Baltimore, Maryland
  • Anton C. Bizzell, M.D.
  • Medical Officer
  • Division of Pharmacologic Therapies
  • Center for Substance Abuse Treatment
  • Substance Abuse and Mental Health Services Administration
  • Rockville, Maryland
  • Jack Blaine, M.D.
  • Chief of Medications Research Grants Unit
  • National Institute on Drug Abuse
  • National Institutes of Health
  • Bethesda, Maryland
  • Linda Brady, Ph.D.
  • Acting Chief of Molecular and Cellular Neuroscience Research Branch
  • National Institute of Mental Health
  • National Institutes of Health
  • Bethesda, Maryland
  • Judy Braslow
  • Deputy Director for Policy
  • Substance Abuse and Mental Health Services Administration
  • Rockville, Maryland
  • Michael F. Brooks, D.O.
  • Medical Director
  • Saline Community Hospital
  • Greenbrook Recovery Center
  • Saline, Michigan
  • Lawrence Brown, M.D., M.P.H.
  • Senior Vice President
  • Division of Medical Services Evaluation and Research
  • Addiction Research Corporation
  • Brooklyn, New York
  • Andrew Byrne, M.D., B.S.
  • Dependency Specialist, Medical Practitioner
  • Redfern, New South Wales
  • Australia
  • Jim Callahan, Ph.D.
  • Executive Vice President/Chief Executive Officer
  • American Society of Addiction Medicine
  • Chevy Chase, Maryland
  • James C. Carleton, M.S.
  • Director, Narcotic Treatment Programs
  • CODAC Treatment Center, Inc.
  • Providence, Rhode Island
  • Louis Cataldie, M.D.
  • Medical Director
  • Office for Addictive Disorders
  • Department of Health and Hospitals
  • State of Louisiana
  • Baton Rouge, Louisiana
  • Susanne Caviness, Ph.D.
  • Captain, U.S. Public Health Service
  • Division of State and Community Assistance
  • Center for Substance Abuse Treatment
  • Substance Abuse and Mental Health Services Administration
  • Rockville, Maryland
  • Richard Christensen, P.A., CAS
  • Vice President and Director of Medical Services
  • Community Medical Services
  • Phoenix, Arizona
  • Darrell Christian, Ph.D.
  • Clinical Psychologist
  • New Leaf Treatment Center
  • Concord, California
  • Barbara Cimaglio
  • Administrator
  • Office of Alcohol and Drug Abuse Programs
  • Department of Human Services
  • State of Oregon
  • Salem, Oregon
  • H. Westley Clark, M.D., J.D., M.P.H., CAS, FASAM
  • Director
  • Center for Substance Abuse Treatment
  • Substance Abuse and Mental Health Services Administration
  • Rockville, Maryland
  • Denise Clayborn, Ph.D.
  • Human Services Adult and Opioid Replacement Consultant
  • Office of Substance Abuse Services
  • Department of Mental Health, Mental Retardation and Substance Abuse Services
  • Commonwealth of Virginia
  • Richmond, Virginia
  • Edward J. Cone, Ph.D.
  • Chief Executive Officer
  • Conechem Research
  • Severna Park, Maryland
  • Michael Couty, M.A.
  • Director
  • Division of Alcohol and Drug Abuse
  • Department of Mental Health
  • State of Missouri
  • Jefferson City, Missouri
  • Michael J. Crookston, M.D.
  • Psychiatrist, Chemical Dependency Services
  • LDS Hospital
  • Salt Lake City, Utah
  • Denise Curry
  • Chief of Liaison Unit
  • Office of Diversion Control
  • Drug Enforcement Administration
  • Washington, District of Columbia
  • Joy Davidoff
  • Coordinator of Addiction Medicine
  • Office of Alcoholism and Substance Abuse Services
  • State of New York
  • Albany, New York
  • Peter A. DeMaria, Jr., M.D., FASAM
  • Associate Professor of Psychiatry and Human Behavior
  • Jefferson Medical College
  • Thomas Jefferson University
  • Philadelphia, Pennsylvania
  • Doug DeShong
  • Senior Product Manager, Suboxone
  • Schering
  • Kenilworth, Texas
  • Pamela Detrick, Ph.D., ARNPC
  • Assistant Professor
  • School of Nursing
  • University of Miami
  • Miami, Florida
  • Herman I. Diesenhaus, Ph.D.
  • Buprenorphine Workgroup Coordinator
  • Office of Evaluation, Scientific Analysis and Synthesis
  • Center for Substance Abuse Treatment
  • Substance Abuse and Mental Health Services Administration
  • Rockville, Maryland
  • Alice Diorio
  • President
  • The Vermont Harm Reduction Coalition
  • Co‐Director, The New England Chapter of the National Alliance of Methadone Advocates
  • Putney, Vermont
  • Martin C. Doot, M.D.
  • Chief
  • Division of Addiction Medicine
  • Addiction Medicine/Family Practice
  • Lutheran General Hospital Advocate
  • Des Plaines, Illinois
  • Alfonzo Dorsey
  • Director of Quality Control
  • Substance Abuse Treatment and Recovery
  • Department of Social and Rehabilitative Services
  • State of Kansas
  • Topeka, Kansas
  • Karen Downey, Ph.D.
  • Assistant Professor
  • Research Division on Substance Abuse
  • Department of Psychiatry and Behavioral Neurosciences
  • Wayne State University
  • Detroit, Michigan
  • Michael Duffy, R.N., CD
  • Acting Assistant Secretary
  • Office of Alcohol and Drug Abuse
  • Department of Health and Hospitals
  • State of Louisiana
  • Baton Rouge, Louisiana
  • Joel Egerston
  • Special Assistant to the Director
  • National Institute on Drug Abuse
  • National Institutes of Health
  • Bethesda, Maryland
  • John P. Epling, M.D.
  • 2303 Line Avenue
  • Shreveport, Louisiana
  • Virginia H. Ervin, B.S.N., CARN, COHN
  • Utilization Review Case Manager
  • Department of Alcohol and Other Drug Abuse Services
  • State of South Carolina
  • Columbia, South Carolina
  • Garland S. Ferguson
  • Director, Division of Treatment Services
  • Bureau of Alcohol and Drug Abuse Prevention
  • Department of Health
  • State of Arkansas
  • Freeway Medical Center
  • Little Rock, Arkansas
  • Michael Fingerhood, M.D.
  • Associate Professor of Medicine
  • Center for Chemical Dependence
  • Johns Hopkins Bayview Medical Center
  • Baltimore, Maryland
  • Gary Fisher, Ph.D.
  • Director and Professor
  • Center for the Application of Substance Abuse Technologies
  • University of Nevada, Reno
  • Reno, Nevada
  • Luceille Fleming
  • Director
  • Department of Alcohol and Drug Addiction Services
  • State of Ohio
  • Columbus, Ohio
  • Paul Fudala, Ph.D.
  • Clinical Toxicologist
  • Philadelphia VA Medical Center
  • Philadelphia, Pennsylvania
  • Robert Fuller, M.D.
  • Director
  • Division of Clinical & Preventative Research
  • National Institute on Alcohol Abuse and Alcoholism
  • National Institutes of Health
  • Rockville, Maryland
  • George R. Gilbert, J.D.
  • Director, Office of Policy Coordination and Planning
  • Center for Substance Abuse Treatment
  • Substance Abuse and Mental Health Services Administration
  • Rockville, Maryland
  • Daniel J. Glatt, M.D., M.P.H.
  • Fellow, Substance Abuse
  • San Francisco VA Medical Center
  • San Francisco, California
  • William Glatt, M.D.
  • Primary Care Physician
  • Internal Medicine and Addiction Medicine
  • South San Francisco, California
  • Angel A. González, M.D.
  • Senior Surgeon, U.S. Public Health Service
  • Division of Pharmacologic Therapies
  • Center for Substance Abuse Treatment
  • Substance Abuse and Mental Health Services Administration
  • Rockville, Maryland
  • Marc Gourevitch, M.D.
  • Medical Director
  • Division of Substance Abuse
  • Albert Einstein College of Medicine
  • Yeshiva University
  • Bronx, New York
  • Prakash L. Grover, Ph.D., M.P.H.
  • Senior Science Advisor
  • Center for Substance Abuse Treatment
  • Substance Abuse and Mental Health Services Administration
  • Rockville, Maryland
  • Jack Gustafson
  • Executive Director
  • National Association of State Alcohol and Drug Abuse Directors
  • Washington, District of Columbia
  • Susan W. Haikalis, LCSW
  • Director
  • HIV Services and Treatment Support
  • San Francisco AIDS Foundation
  • San Francisco, California
  • William F. Haning III, M.D., FASAM
  • Associate Dean
  • John A. Burns School of Medicine
  • University of Hawaii
  • Honolulu, Hawaii
  • Michael Harle
  • President/Executive Director
  • Gaudenzia, Inc.
  • Norristown, Pennsylvania
  • Dana Harlow, LISW, CCDC III‐E
  • Manager
  • Department of Alcohol and Drug Addiction Services
  • State of Ohio
  • Columbus, Ohio
  • Reva Harris, M.B.A., B.S.
  • Fellow
  • Office of Congressman Charles Rangel
  • Washington, District of Columbia
  • John Harsany, Jr., M.D.
  • Medical Director
  • Riverside County Substance Abuse Program
  • Hemet, California
  • Dory Hector
  • State Methadone Authority
  • Division of Substance Abuse Services
  • Department of Mental Health and Mental Retardation
  • State of Alabama
  • Montgomery, Alabama
  • Renata J. Henry
  • Director
  • Division of Alcoholism, Drug Abuse, and Mental Health
  • Department of Health and Social Services
  • State of Delaware
  • New Castle, Delaware
  • James Herrera, M.A., NCC, LPCC
  • Senior Counselor
  • Center on Alcoholism, Substance Abuse, and Addictions
  • University of New Mexico
  • Albuquerque, New Mexico
  • Edward J. Higgins, M.A.
  • Executive Director
  • Jersey Shore Addiction Services, Inc.
  • Asbury Park, New Jersey
  • John Hopper, M.D.
  • Medical Director
  • UPC Opiate Dependence Treatment
  • Detroit, Michigan
  • Elizabeth F. Howell, M.D.
  • Senior Medical Editor
  • Atlanta, Georgia
  • Ronald J. Hunsicker, D.Min., FACATA
  • President/Chief Executive Officer
  • National Association of Addiction Treatment Providers
  • Lititz, Pennsylvania
  • Ray Hylton, M.S.N., R.N.
  • Division of Pharmacologic Therapies
  • Center for Substance Abuse Treatment
  • Substance Abuse and Mental Health Services Administration
  • Rockville, Maryland
  • Jerome Jaffe, M.D.
  • Clinical Professor of Psychiatry
  • University of Maryland
  • Towson, Maryland
  • Donald R. Jasinski, M.D.
  • Chief
  • Center for Chemical Dependence
  • Johns Hopkins Bayview Medical Center
  • Baltimore, Maryland
  • Kimberly Johnson
  • Director
  • Office of Substance Abuse
  • State of Maine
  • Augusta, Maine
  • Rolley E. Johnson, Pharm.D.
  • Associate Professor
  • Department of Psychiatry and Behavioral Sciences
  • Behavioral Pharmacology Research Unit
  • Johns Hopkins University School of Medicine
  • Baltimore, Maryland
  • Linda R. Wolf Jones, D.S.W.
  • Executive Director
  • Therapeutic Communities of America
  • Washington, District of Columbia
  • Herman Joseph, Ph.D.
  • Research Scientist
  • Office of Alcoholism and Substance Abuse Services
  • State of New York
  • New York, New York
  • George Kanuck
  • Public Health Analyst
  • Center for Substance Abuse Treatment
  • Substance Abuse and Mental Health Services Administration
  • Rockville, Maryland
  • Janice F. Kauffman, M.P.H., R.N., CAS
  • Director, Substance Abuse Treatment Services
  • North Charles, Inc.
  • Director, Addiction Psychiatry Service
  • Brigham and Women’s Hospital
  • Assistant Professor of Psychiatry
  • Harvard Medical School
  • Somerville, Massachusetts
  • Chris Kelly
  • President, DC‐Chapter
  • Advocates for Recovery Through Medicine
  • Washington, District of Columbia
  • Maureen Kerrigan, J.D.
  • Policy and Legislative Analyst
  • Center for Substance Abuse Treatment
  • Substance Abuse and Mental Health Services Administration
  • Amesbury, Massachusetts
  • Steven Kipnis, M.D., FACP
  • Medical Director
  • Blaisdell Addiction Treatment Center
  • Orangeburg, New York
  • Monika Koch, M.D.
  • Addiction Psychiatrist
  • Friends Research Associates
  • Berkeley, California
  • Thomas R. Kosten, M.D.
  • Professor
  • Department of Psychiatry
  • Yale University
  • American Academy of Addiction Psychiatry
  • VA Connecticut Healthcare System
  • West Haven, Connecticut
  • Ottis L. Layne, M.D.
  • Medical Director
  • Emergency Department
  • Hill County Memorial Hospital
  • Fredericksburg, Texas
  • Ira Lubell, M.D., M.P.M.
  • Medical Director
  • Santa Clara Valley Medical Center
  • San Jose, California
  • Robert Lubran, M.S., M.P.A.
  • Director
  • Division of Pharmacologic Therapies
  • Center for Substance Abuse Treatment
  • Substance Abuse and Mental Health Services Administration
  • Rockville, Maryland
  • James W. Luckey, Ph.D.
  • Associate Director
  • Substance Abuse Research Group
  • Westat
  • Rockville, Maryland
  • Stephen Magura, Ph.D., CSW
  • Director
  • Institute for Treatment and Services Research
  • National Development and Research Institutes
  • New York, New York
  • Kathleen Masis, M.D.
  • Medical Officer for Chemical Dependency
  • Office of Health Care
  • Billings Area Indian Health Service
  • U.S. Department of Health and
  • Human Services
  • Billings, Montana
  • Stephen S. Mason
  • Director
  • Office of Behavioral Health Services
  • Division of Alcoholism and Drug Abuse
  • Department of Health and Human Resources
  • State of West Virginia
  • Charleston, West Virginia
  • Mary Mayhew
  • Congressional Division
  • National Institute on Drug Abuse
  • National Institutes of Health
  • Bethesda, Maryland
  • Philip S. McCullough
  • Director
  • Bureau of Substance Abuse Services
  • Division of Supportive Living
  • Department of Health and Family Services
  • State of Wisconsin
  • Madison, Wisconsin
  • John J. McGovern, CSW
  • Director
  • Clinical Services
  • HELP/Project Samaritan, Inc.
  • Bronx, New York
  • Kathleen McGowan, J.D.
  • Legislative Assistant
  • Office of Senator Moynihan
  • Washington, District of Columbia
  • Paul McLaughlin
  • Executive Director
  • Hartford Dispensary
  • Hartford, Connecticut
  • John Mendelson, M.D.
  • Associate Clinical Professor
  • Psychiatry and Medicine
  • Drug Dependence Research Center
  • University of California at San Francisco
  • San Francisco, California
  • Robert Miller, M.A.
  • Operations Manager
  • Office of Alcohol and Drug Abuse Programs
  • Department of Human Services
  • State of Oregon
  • Salem, Oregon
  • Sharon Morello, R.N., B.S.N.
  • Nursing Care Evaluator
  • Division of Substance Abuse
  • Department of Mental Health, Retardation and Hospitals
  • State of Rhode Island
  • Cranston, Rhode Island
  • Don Myers
  • Treatment Field Manager/State Methadone Authority
  • Alcohol and Drug Abuse Division
  • Department of Human Services
  • State of Colorado
  • Denver, Colorado
  • David K. Nace, M.D.
  • Senior Vice President
  • United Behavioral Health
  • Philadelphia, Pennsylvania
  • Madeline A. Naegle, Ph.D., R.N., C.S., FAAN
  • Associate Professor
  • Division of Nursing
  • School of Education
  • New York University
  • New York, New York
  • Susan F. Neshin, M.D.
  • Medical Director
  • Jersey Shore Addiction Service, Inc.
  • Asbury Park, New Jersey
  • Thomas Nicholson, Ph.D., M.P.H., M.A.Ed.
  • Professor
  • Department of Public Health
  • Western Kentucky University
  • Bowling Green, Kentucky
  • Edward V. Nunes, M.D.
  • Research Psychiatrist and Assistant Professor of Clinical Psychiatry
  • New York State Psychiatric Institute
  • New York, New York
  • David Ockert, D.S.W.
  • Executive Director
  • Parallax Center
  • New York, New York
  • Kerry O’Neil
  • Chief of Treatment Services
  • Division of Substance Abuse
  • Department of Mental Health, Retardation and Hospitals
  • State of Rhode Island
  • Cranston, Rhode Island
  • Patricia Isbell Ordorica, M.D.
  • James A. Haley Veterans’ Hospital
  • Tampa, Florida
  • Mark Parrino, M.P.A.
  • President
  • American Methadone Treatment Association
  • New York City, New York
  • David Pating, M.D.
  • Medical Director
  • Chemical Dependency Recovery Program
  • Kaiser San Francisco
  • San Francisco, California
  • J. Thomas Payte, M.D.
  • Medical Director
  • Drug Dependence Associates
  • San Antonio, Texas
  • Lillian Pickup
  • Administrator
  • Department of Alcoholism and Substance Abuse
  • State of Illinois
  • Chicago, Illinois
  • Deborah Powers
  • State Methadone Authority
  • Bureau of Substance Abuse Services
  • State of Wisconsin
  • Madison, Wisconsin
  • Sandi Record
  • Director
  • Treatment, Prevention and Program Department
  • Office for Addiction Disorder, Alcohol and Drug Abuse
  • State of Louisiana
  • Baton Rouge, Louisiana
  • Nicholas Reuter, M.P.H.
  • Division of Pharmacologic Therapies
  • Center for Substance Abuse Treatment
  • Substance Abuse and Mental Health Services Administration
  • Rockville, Maryland
  • Michael Rizzi
  • Deputy Director
  • CODAC Treatment Centers
  • Cranston, Rhode Island
  • Diedre Roach, M.D.
  • Administrator
  • Alcohol Prevention and Recovery
  • Administration
  • District of Columbia Department of Health
  • Washington, District of Columbia
  • Barbara T. Roberts, Ph.D.
  • Policy Analyst
  • White House Office of National Drug Control Policy
  • Washington, District of Columbia
  • June Ross, B.S., ICADC
  • Executive Director
  • 12 12, Inc.
  • Tulsa, Oklahoma
  • Pedro Ruiz, M.D.
  • Mental Sciences Institute
  • University of Texas
  • Houston, Texas
  • Richard Saitz, M.D., M.P.H.
  • Associate Professor of Medicine
  • Clinical Addiction Research and Education (CARE) Unit
  • Section of General Internal Medicine
  • Boston Medical Center and Boston University School of Medicine
  • Boston, Massachusetts
  • Jeff Samet, M.D., M.A., M.P.H.
  • Associate Professor
  • Boston University School of Medicine
  • Boston, Massachusetts
  • Sidney Schnoll, M.D., Ph.D.
  • Professor and Chairman
  • Addiction Medicine
  • Medical College of Virginia
  • Virginia Commonwealth University
  • Richmond, Virginia
  • Mary Schumacher
  • Director
  • Behavioral Health Services Division
  • Department of Health
  • State of New Mexico
  • Santa Fe, New Mexico
  • Ian A. Shaffer, M.D.
  • Principal
  • Ian A. Shaffer & Associates, L.L.C.
  • Reston, Virginia
  • Steve Shoptow, Ph.D.
  • Integrated Substance Abuse Programs
  • University of California at Los Angeles
  • Los Angeles, California
  • Larry Siegel, M.D.
  • Senior Deputy Director
  • Administrator
  • Addiction Prevention and Recovery Administration
  • District of Columbia Department of Health
  • Washington, District of Columbia
  • Cynthia L. Spencer, D.O.
  • Medical Director
  • Substance Abuse Services
  • Lansing, Michigan
  • George Stavros, M.D.
  • Medical Director
  • Community Medical Services
  • Phoenix, Arizona
  • Richard T. Suchinsky, M.D.
  • Associate Chief for Addictive Disorders
  • Mental Health and Behavioral Sciences Service
  • U.S. Department of Veteran Affairs
  • Washington, District of Columbia
  • Kenneth Sunamoto, M.D.
  • Medical Director
  • Drug Addiction Services of Hawaii, Inc.
  • Honolulu, Hawaii
  • Karen Tannert, R.Ph.
  • Chief Pharmacist
  • Drugs and Medical Devices Division
  • Department of Health
  • State of Texas
  • Austin, Texas
  • Tony Tommasello, Ph.D.
  • Department of Pharmacy Practice and Science
  • University of Maryland School of Pharmacy
  • Baltimore, Maryland
  • Alan Trachtenberg, M.D.
  • Medical Director
  • Division of Pharmacologic Therapies
  • Center for Substance Abuse Treatment
  • Substance Abuse and Mental Health Services Administration
  • Rockville, Maryland
  • Donald Weinbaum
  • Coordinator
  • Criminal Justice and Block Grant Planning Unit
  • Division of Addiction Services
  • Department of Health
  • State of New Jersey
  • Trenton, New Jersey
  • Richard Weisskopf
  • Manager
  • Methadone Treatment Services
  • Office of Alcoholism and Substance Abuse
  • Department of Human Services
  • State of Illinois
  • Chicago, Illinois
  • Donald R. Wesson, M.D.
  • Consultant, CNS Medications Development
  • Oakland, California
  • Charles L. Whitfield, M.D.
  • Private Practice of Addiction Medicine
  • Atlanta, Georgia
  • Cheryl Williams
  • Director
  • Division of Drug and Alcohol Program Licensure
  • Department of Health
  • State of Pennsylvania
  • Harrisburg, Pennsylvania
  • Jaslene Williams
  • Assistant Director
  • Division of Mental Health
  • U.S. Virgin Islands
  • Christiansted, Virgin Islands
  • Janet Wood
  • Director
  • Alcohol and Drug Abuse Division
  • Department of Human Services
  • State of Colorado
  • Denver, Colorado
  • William Wood, M.D.
  • Chief Medical Officer
  • ValueOptions
  • Falls Church, Virginia
  • George E. Woody, M.D.
  • Professor
  • Department of Psychiatry
  • Treatment Research Institute
  • Philadelphia, Pennsylvania
  • Richard Yoast, Ph.D.
  • Director
  • Office of Alcohol
  • American Medical Association
  • Chicago, Illinois
  • Leah Young
  • Public Affairs Specialist
  • Office of Communication and External Liaison
  • Center for Substance Abuse Treatment
  • Substance Abuse and Mental Health Services Administration
  • Rockville, Maryland
  • Edward Zborower
  • Program Representative/State Methadone Authority
  • Bureau of Substance Abuse and General Mental Health
  • Department of Health Services
  • State of Arizona
  • Phoenix, Arizona
  • Steve Zukin
  • Division of Treatment Research and Development
  • National Institute on Drug Abuse
  • National Institutes of Health
  • Bethesda, Maryland
Bookshelf ID: NBK64242

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (1.1M)

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...